BIDEM Tablet (Dienogest)

Adult dose

Take 1 tablet daily without a break. If possible, take it with a small amount of water at the same time each day; it may be taken regardless of meals. Take the tablets continuously, regardless of vaginal bleeding. Once all the tablets in the current pack have been taken, start the next pack without a break. You may start taking the tablets on any day of the menstrual cycle. The effect may be reduced if you miss a dose or vomit or have diarrhea within 3-4 hours after taking this medicine. If you have missed 1 or more tablets, take 1 tablet as soon as you remember, then continue taking the tablets at the usual time the next day. If a dose was not absorbed because of vomiting or diarrhea, take 1 additional tablet in the same way. Patients with renal impairment: No dosage adjustment is necessary in patients with renal impairment.

This medication should not be used during pregnancy or if pregnancy is suspected. It should not be administered to patients with coagulation disorders, heart and cerebrovascular diseases, or a history of such conditions. Patients with severely impaired liver function or liver tumors or a history of such are also advised against using this medication. It should not be given to patients with malignant tumors suspected to be hormone-dependent or patients with unexplained vaginal bleeding. Additionally, patients with allergies to any ingredients in this medication or specific genetic metabolic disorders such as lactose intolerance should not take this medication. Patients with severe uterine bleeding should be cautious when using this medication as it may worsen bleeding; if bleeding is severe or persists, they should consider discontinuing use as it may lead to anemia. Patients with circulatory issues or risk factors for thrombosis should be particularly careful before and after taking this medication and may consider temporarily stopping use if they are immobile for extended periods. For cancer patients, particularly those at risk for breast cancer, careful evaluation of risks and benefits is recommended before taking this medication. Patients at risk for osteoporosis should also consult their doctor regarding potential impacts on bone health while taking this medication. Patients with a history of depression should closely monitor their condition as symptoms may worsen during treatment; discontinuation may be necessary in severe cases. Diabetes patients should be monitored closely as blood sugar control may be affected. Women with a history of ectopic pregnancy or tubal dysfunction should make a careful decision about using this medication as the risk of ectopic pregnancy may increase. During treatment, menstrual patterns may change, and side effects such as headaches, breast discomfort, mood changes, and acne may occur. Furthermore, as this medication is metabolized in the liver, it may interact with other drugs; it is essential to inform healthcare providers of any other medications being taken. Pregnant or breastfeeding women are advised against using this medication, especially if contraception is needed, where non-hormonal methods are preferred. This medication should not be given to children or the elderly, and prior consultation with a physician is required. Store this medication out of reach of children and keep it in its original container away from light.

• Petechiae
• irregular bleeding
• amenorrhea
• headache
• breast discomfort
• depressed mood
• acne
• anemia
• weight gain
• weight loss

Store this medication in a tightly closed container to protect it from air and moisture, preferably at a cool temperature below 25 degrees. This will help maintain the medication's effectiveness for a longer period.

Appearance

White to off-white round tablets

Package unit

Box - 28 tablets/PITP